A revolution in the treatment and rehabilitation of muscle/tendon injuries is on its way with the development of a ground-breaking new intelligent technology developed at Griffith University and the University of Auckland.
Called iTraining, the biomedically engineered system works in real time to provide feedback on the stresses and strains that affect a specific muscle or tendon, either following injury or in the prevention of injury.
Following the award of a grant of nearly $1m from Australian Research Council and industry partners, Professor David Lloyd, from Griffith’s Menzies Health Institute Queensland, and other colleagues are now preparing to undertake a large three-part study that will focus on the Achilles tendon.
“Currently the mechanical environment of the Achilles tendon is poorly understood because of difficulties associated with directly measuring the stresses and strains experienced throughout the tendon in daily activities. If these issues can be overcome, it will be possible to identify the loading conditions required to facilitate favourable structural and mechanical adaption of healthy, as well as injured or diseased Achilles tendons,” says Professor Lloyd.
Potential to radically transform
“The technology to achieve this goal is now within reach and has the potential to radically transform the way athletic training and rehabilitation programs for the Achilles tendon are designed and monitored.
“The approach will allow the trainer to identify an individual’s optimal loading conditions for positive structural and mechanical adaption of their Achilles tendon, by using methods that integrate the necessary technologies to measure stress-strain of the tendon in real time.”
The study will be broken into three parts. Part A will aim to determine the optimal loading conditions required to alter the structural, mechanical and biochemical properties of the Achilles tendon; Part B will be to develop the iTraining system which will entail participants wearing next generation wearable sensors coupled with computer models, to provide real-time biofeedback of the tendon’s mechanical behaviour; Part C will determine the efficacy of an iTraining program to alter the structural properties of the human Achilles tendon.
Professor Lloyd says the iTraining approach will be likely to have broad application to other tendons and musculoskeletal tissues within the body.
“This new ‘intelligent’ approach to training and rehabilitation is at the forefront of modern developments in biomechanics, rehabilitation engineering, sports science and sports medicine.
“iTraining has the potential to radically transform the practice of exercise prescription across the full spectrum from elite performance to rehabilitation of acute and chronic musculoskeletal conditions,” he says.
“A key feature of this approach is that feedback is subject specific and therefore consistent with the concept of the ‘quantitative’ self and the trend in science and practice is of course, to move towards models of personalised medicine and rehabilitation.”
Professor Lloyd says he envisages that the technology could be available in public gyms and physiotherapy practices in as little as four years.
Learn more: Technology set to personalise tendon and tissue injury rehab
The Latest on: Personalised medicine
[google_news title=”” keyword=”personalised medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Personalised medicine
- Personalized 'cocktails' of antibiotics, probiotics and prebiotics hold promise in treating IBS, pilot study findson April 26, 2024 at 3:10 pm
Personalized "cocktails" of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), according to research presented at the ESCMID ...
- 'Despite promise, personalized medicine for head and neck cancers facing hurdles'on April 26, 2024 at 3:45 am
Improved efficacy: By identifying specific mutations driving tumour growth, personalized medicine allows for targeted therapies that have a higher success rate compared to ‘one-size-fits-all’ ...
- British patients test world’s first personalised MRNA cancer jab for melanomaon April 25, 2024 at 8:09 pm
The ‘gamechanger’ jab works by telling the body to hunt down cancer cells and prevent the deadly disease from coming back ...
- Examining the impact of gene-based breeding on agriculture and medicineon April 25, 2024 at 10:22 am
A research team has demonstrated that gene-based breeding (GBB) offers a transformative approach to advancing plant and animal breeding, showing remarkable predictability, speed, and ...
- Calories, gut health and food as medicine — with AdventHealth’s Karen Corbin and a local culinary medicine specialist (podcast)on April 24, 2024 at 9:00 pm
In this episode of the Inspiring Wholeness podcast, AdventHealth’s Karen Corbin and Allison Harrell, sole practitioner and culinary medicine specialist, discuss calories, gut health and food as ...
- Moderna and OpenAI Collaborate To Advance mRNA Medicineon April 24, 2024 at 4:11 am
Generative AI will help advance Moderna’s broad and diverse portfolio to maximize the Company’s impact on patients ...
- AI could predict whether cancer treatments will work, experts say: ‘Exciting time in medicine'on April 23, 2024 at 3:00 am
A chemotherapy alternative called immunotherapy is showing promise in treating cancer — and a new artificial intelligence tool could help ensure that patients have the best possible experience.
- 8 Clinical Trials That Will Shape Medicine in 2024on April 22, 2024 at 10:13 am
One of the exciting things about modern medicine is that it is making increasingly rapid advancements in a number of key areas. These advancements could have a major impact on the future of medicine.
- Progesterone Therapy in Demand for Personalized Medicine: Market to Reach US$4.8 Billion by 2034 | Future Market Insights, Inc.on April 22, 2024 at 3:30 am
After extensive research, the progesterone market suggests an upward trajectory from 2024 to 2034, inferring a healthy CAGR of 12.30%. With preliminary valuations of US$ 1.50 billion in 2024, the ...
- REPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriateon April 22, 2024 at 12:29 am
Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO ...
via Bing News